American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritis

This publication has 83 references indexed in Scilit:

• 2012 Update of the 2008 American College of Rheumatology recommendations for the use of disease‐modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis
  Arthritis Care & Research, 2012
• Trends in the incidence, demographics, and outcomes of end-stage renal disease due to lupus nephritis in the US from 1995 to 2006
  Arthritis & Rheumatism, 2011
• Azathioprine versus mycophenolate mofetil for long-term immunosuppression in lupus nephritis: results from the MAINTAIN Nephritis Trial
  Annals of the Rheumatic Diseases, 2010
• Influence of race/ethnicity on response to lupus nephritis treatment: the ALMS study
  Rheumatology, 2009
• Protective effect of hydroxychloroquine on renal damage in patients with lupus nephritis: LXV, data from a multiethnic US cohort
  Arthritis Care & Research, 2009
• Mycophenolate Mofetil versus Cyclophosphamide for Induction Treatment of Lupus Nephritis
  Journal of the American Society of Nephrology, 2009
• Randomized, Controlled Trial of Prednisone, Cyclophosphamide, and Cyclosporine in Lupus Membranous Nephropathy
  Journal of the American Society of Nephrology, 2009
• Risk and protective factors for thrombosis in systemic lupus erythematosus: results from a large, multi-ethnic cohort
  Annals of the Rheumatic Diseases, 2009
• Changes in the Incidence of Endstage Renal Disease Due to Lupus Nephritis in the United States, 1996–2004
  The Journal of Rheumatology, 2009
• Successful Treatment of Class V+IV Lupus Nephritis with Multitarget Therapy
  Journal of the American Society of Nephrology, 2008